Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,112.20 -206.04 -1.35%
S&P 500 1,628.93 -22.88 -1.39%
Nasdaq 3,443.20 -38.98 -1.12%
Ticker Volume Price Price Delta
STOXX 50 2,683.98 -16.95 -0.63%
FTSE 100 6,348.82 -25.39 -0.40%
DAX 8,197.08 -32.43 -0.39%
Ticker Volume Price Price Delta
Nikkei 13,245.20 +237.94 1.83%
Hang Seng 20,986.90 -238.99 -1.13%
S&P/ASX 200 4,861.38 +47.03 0.98%
  • Fund Type: SICAV
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Credit Suisse SICAV Lux Equity Biotechnology

+ Add to Watchlist

CLTLU:LX

242.8600 USD 0.00000.00%

As of 11:25:06 ET on 06/18/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Credit Suisse SICAV Lux Equity Biotechnology (CLTLU)

Open: - High - Low: - Primary Exchange: Luxembourg
Volume: 0 52-Week Range: - Beta vs NBI: -

ETF Chart for CLTLU

No chart data available.
  • CLTLU:LX 242.8600
  • 1D
  • 1M
  • 1Y
242.8600
Interactive CLTLU Chart

Previous Close

Fund Profile & Information for CLTLU

Credit Suisse SICAV (Lux) Equity Biotechnology is a SICAV incorporated in Luxembourg. The Fund's objective is long-term capital growth. The Fund invests in a portfolio of equity securities of biotechnology companies worldwide.

Inception Date: Telephone: -
Managers: IRENE B PUTTNER
Web Site: www.credit-suisse.com

Fundamentals for CLTLU

NAV -
Assets (M) (on 2013-06-18) 162.2248
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for CLTLU

No dividends reported

Performance for CLTLU

1-Month - 1-Year -
3-Month - 3-Year -
Year To Date - 5-Year -
Expense Ratio -

Top Fund Holdings for CLTLU

Filing Date: 04/29/2013
Name Position Value % of Total
Gilead Sciences Inc 260,484 13,308,128 8.018%
Celgene Corp 101,638 12,041,054 7.255%
Biogen Idec Inc 49,745 11,123,479 6.702%
Vertex Pharmaceuticals Inc 127,000 9,947,910 5.994%
Amgen Inc 79,973 8,530,720 5.140%
Regeneron Pharmaceuticals Inc 38,000 8,188,240 4.933%
BioMarin Pharmaceutical Inc 125,444 8,081,102 4.869%
Onyx Pharmaceuticals Inc 82,000 7,859,700 4.736%
Alexion Pharmaceuticals Inc 74,752 7,375,032 4.443%
Incyte Corp Ltd 245,000 5,394,900 3.250%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil